Trump’s Care Questioned; U.K. Won’t Vaccinate Everyone; Nobel Awarded

News

Note that some links may require registration or subscription.

President Trump’s kitchen sink regimen for COVID-19 “isn’t necessarily good quality care.” (USA Today)

His impromptu motorcade and meetings with first responders at the Walter Reed National Military Medical Center where he’s being treated for COVID-19 were criticized for risk of infecting others. (Reuters)

Suggestions that Trump could be discharged today “astonished” infectious disease specialists, who warned he remains in the risky period when COVID-19 can worsen suddenly. (Washington Post)

The White House is cooperating with New Jersey’s contact tracing efforts for fundraiser events there where Trump appeared hours before testing positive. (The Hill)

But it hasn’t appeared to reach out to those Trump met in close quarters or at a rally otherwise. (Washington Post)

Trump’s diagnosis cast shade on the White House strategy of testing without mask-wearing or social distancing. (Kaiser Health News)

It’s almost as if politicians haven’t gotten the message that the laws of virus transmission apply to them, too. (STAT)

As of 8:00 a.m. ET Monday, the estimated U.S. COVID-19 toll reached 7,418,738 cases and 209,734 deaths. That’s up 302,282 cases and 4,972 deaths in the last week.

MIS-C: it’s not just for kids anymore. Morbidity and Mortality Weekly Report detailed 27 cases of what it’s calling multisystem inflammatory syndrome in adults (MIS-A).

Only higher-risk groups will get a coronavirus vaccine in Britain, according to the country’s vaccine task force chair. (Reuters)

New York City will put 20 coronavirus hotspots in the city back into lockdown — shutting schools, nonessential businesses, and indoor and outdoor dining. (New York Times)

Go figure: A doctor in Greece who invited “mask- and COVID-19 deniers” to join him for a shift in the ED got no takers. (Newsweek)

The FDA sent a warning letter to Nephron Pharmaceuticals for suggesting its budesonide inhalation solution could treat COVID-19 symptoms, for which the drug is not approved.

CNN reports on another case of apparent COVID-19 reinfection months after a first bout.

In other news:

Leave a Reply

Your email address will not be published. Required fields are marked *